Følg
John B Buse
John B Buse
Verificeret mail på med.unc.edu - Startside
Titel
Citeret af
Citeret af
År
Liraglutide and cardiovascular outcomes in type 2 diabetes
SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ...
New England Journal of Medicine 375 (4), 311-322, 2016
69312016
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes Spectrum 25 (3), 154-171, 2012
66692012
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes …
DM Nathan, JB Buse, MB Davidson, E Ferrannini, RR Holman, R Sherwin, ...
Diabetes care 32 (1), 193-203, 2009
5730*2009
Williams textbook of endocrinology E-Book
S Melmed, KS Polonsky, PR Larsen, HM Kronenberg
Elsevier Health Sciences, 2015
43112015
Effects of intensive blood-pressure control in type 2 diabetes mellitus
ACCORD Study Group
New England Journal of Medicine 362 (17), 1575-1585, 2010
42952010
Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ...
Diabetes care 41 (12), 2669-2701, 2018
40652018
Follow-up report on the diagnosis of diabetes mellitus
S Genuth, K Alberti, P Bennett, J Buse, R DeFronzo, R Kahn, J Kitzmiller, ...
Diabetes care 26 (11), 3160-3168, 2003
38472003
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 38 (1), 140-149, 2015
36042015
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
R Kahn, J Buse, E Ferrannini, M Stern
Diabetes care 28 (9), 2289-2304, 2005
35992005
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ...
New England Journal of Medicine 373 (3), 232-242, 2015
30892015
Strategies for multivessel revascularization in patients with diabetes
ME Farkouh, M Domanski, LA Sleeper, FS Siami, G Dangas, M Mack, ...
New England journal of medicine 367 (25), 2375-2384, 2012
21242012
Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association …
DM Nathan, JB Buse, MB Davidson, RJ Heine, RR Holman, R Sherwin, ...
Diabetes care 29 (8), 1963-1972, 2006
20272006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
JB Buse, HN Ginsberg, GL Bakris, NG Clark, F Costa, R Eckel, V Fonseca, ...
Circulation 115 (1), 114-126, 2007
20112007
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American …
JS Skyler, R Bergenstal, RO Bonow, J Buse, P Deedwania, EAM Gale, ...
Circulation 119 (2), 351-357, 2009
19492009
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
JB Buse, J Rosenstock, G Sesti, WE Schmidt, E Montanya, JH Brett, ...
The Lancet 374 (9683), 39-47, 2009
19352009
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ...
New England Journal of Medicine 377 (13), 1228-1239, 2017
19222017
2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ...
Diabetes care 43 (2), 487-493, 2020
17442020
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse, RR Henry, J Han, DD Kim, MS Fineman, AD Baron, ...
Diabetes care 27 (11), 2628-2635, 2004
16342004
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
JB Buse, AC Moses
US Patent 6,591,125, 2003
15252003
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
DJ Drucker, JB Buse, K Taylor, DM Kendall, M Trautmann, D Zhuang, ...
The Lancet 372 (9645), 1240-1250, 2008
12372008
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20